HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlo Heirman Selected Research

trimix

2/2016Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells.
11/2014The potential of antigen and TriMix sonoporation using mRNA-loaded microbubbles for ultrasound-triggered cancer immunotherapy.
9/2014Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula.
7/2012Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient.
6/2011Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma.
5/2009Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlo Heirman Research Topics

Disease

44Neoplasms (Cancer)
12/2020 - 06/2002
13Melanoma (Melanoma, Malignant)
12/2020 - 06/2007
5Inflammation (Inflammations)
11/2011 - 01/2003
3Infections
01/2019 - 07/2008
3Human Influenza (Influenza)
01/2019 - 06/2002
3Neoplasm Metastasis (Metastasis)
01/2018 - 06/2011
2Multiple Myeloma
01/2018 - 10/2014
2Hypersensitivity (Allergy)
11/2011 - 11/2008
2Asthma (Bronchial Asthma)
11/2008 - 11/2004
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1T-Cell Lymphoma (Lymphoma, T Cell)
12/2016
1Pathologic Processes
12/2016
1Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2016
1Wilms Tumor (Wilm's Tumor)
11/2013
1Lethargy
06/2011
1Fever (Fevers)
06/2011
1Delayed Hypersensitivity (Hypersensitivity, Type IV)
06/2011
1HIV Infections (HIV Infection)
06/2011
1Injection Site Reaction
06/2011
1Communicable Diseases (Infectious Diseases)
06/2002

Drug/Important Bio-Agent (IBA)

27Messenger RNA (mRNA)IBA
12/2020 - 06/2002
21AntigensIBA
01/2019 - 09/2003
14VaccinesIBA
01/2019 - 06/2002
8Proteins (Proteins, Gene)FDA Link
10/2019 - 06/2002
7Neoplasm Antigens (Tumor Antigens)IBA
05/2012 - 09/2002
6trimixIBA
02/2016 - 05/2009
5Peptides (Polypeptides)IBA
01/2019 - 08/2003
3Monoclonal AntibodiesIBA
01/2018 - 04/2011
3CytokinesIBA
01/2015 - 11/2008
3Monophenol Monooxygenase (Tyrosinase)IBA
07/2012 - 05/2009
2Immune Checkpoint InhibitorsIBA
01/2019 - 01/2015
2IpilimumabIBA
04/2016 - 04/2011
2MART-1 AntigenIBA
01/2008 - 09/2003
1CD40 Ligand (CD40L)IBA
12/2020
1Formaldehyde (Formol)FDA Link
12/2020
1ParaffinIBA
12/2020
1Mannose ReceptorIBA
10/2019
1NucleoproteinsIBA
01/2019
1HLA-A2 Antigen (HLA A2 Antigen)IBA
01/2019
1AntibodiesIBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1Histone Deacetylase InhibitorsIBA
01/2018
1Immune Checkpoint ProteinsIBA
01/2018
1Bortezomib (Velcade)FDA Link
01/2018
1trametinibIBA
01/2018
1STAT5 Transcription FactorIBA
12/2016
1p80(NPM-ALK) proteinIBA
12/2016
1Biological ProductsIBA
12/2016
1NucleophosminIBA
12/2016
1Hyaluronic Acid (Hyaluronan)IBA
11/2016
1Immunoglobulins (Immunoglobulin)IBA
04/2016
1SolutionsIBA
01/2016
1Interferon alpha-2 (Roferon-A)FDA Link
03/2015
1Cancer VaccinesIBA
11/2014
1Lenalidomide (CC 5013)FDA Link
10/2014
1pomalidomideIBA
10/2014
1Immunomodulating AgentsIBA
10/2014
1N-acetyltalosaminuronic acid (NAT)IBA
09/2014
1WT1 ProteinsIBA
11/2013
1Pharmaceutical PreparationsIBA
02/2013
1Dacarbazine (DIC)FDA LinkGeneric
07/2012
1Protein Sorting Signals (Signal Peptide)IBA
05/2012
1EpitopesIBA
05/2012
1CaspasesIBA
03/2012
1Adenosine Triphosphate (ATP)IBA
03/2012
1CalreticulinIBA
03/2012
1HMGB1 Protein (HMG1)IBA
03/2012
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2011
1SirtuinsIBA
11/2011
1Sirtuin 1IBA
11/2011
1HLA Antigens (Human Leukocyte Antigens)IBA
06/2011
1CTLA-4 AntigenIBA
04/2011
1InterferonsIBA
04/2011
1Interleukin-10 (Interleukin 10)IBA
11/2008
1Interleukin-4 (Interleukin 4)IBA
11/2008
1Fas Ligand Protein (Fas Ligand)IBA
09/2008
1LigandsIBA
09/2008
1Chondroitin Sulfate ProteoglycansIBA
06/2007
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
06/2007
1ChondroitinIBA
06/2007
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
06/2007
1Proteoglycans (Proteoglycan)IBA
06/2007
1InterleukinsIBA
11/2004
1salicylhydroxamic acid (SHAM)IBA
11/2004
1Interleukin-12 (IL 12)IBA
11/2004
1AerosolsIBA
11/2004
1ovalbumin-alumIBA
11/2004
1HLA-C*70 antigenIBA
02/2004
1PPAR-betaIBA
01/2003
1Dextrans (Dextran)FDA Link
06/2002

Therapy/Procedure

23Immunotherapy
01/2018 - 08/2003
11Therapeutics
10/2019 - 06/2011
1Ligation
01/2019
1Microbubbles
11/2014
1Stem Cell Transplantation
10/2014
1Drug Therapy (Chemotherapy)
07/2012
1Intravenous Injections
07/2012
1Injections
07/2012
1Microspheres (Microsphere)
06/2002